Aliberti, Stefano
Amati, Francesco
Pappalettera, Maria
Di Pasquale, Marta
D’Adda, Alice
Mantero, Marco
Gramegna, Andrea
Simonetta, Edoardo
Oneta, Anna Maria
Privitera, Emilia
Gori, Andrea
Bozzi, Giorgio
Peyvandi, Flora
Minoia, Francesca
Filocamo, Giovanni
Abbruzzese, Chiara
Vicenzi, Marco
Tagliabue, Paola
Alongi, Salvatore
Blasi, Francesco
Article History
Received: 6 July 2020
Accepted: 21 September 2020
First Online: 9 October 2020
Ethics approval and consent to participate
: Not applicable.
: Not applicable.
: Prof. Aliberti reports grants and personal fees from Bayer Healthcare, grants and personal fees from Aradigm Corporation, grants and personal fees from Grifols, personal fees from Astra Zeneca, personal fees from Basilea, personal fees from Zambon, personal fees from Novartis, personal fees from Raptor, grants and personal fees from Chiesi, personal fees from Actavis UK Ltd., personal fees from Horizon, grants and personal fees from INSMED, outside the submitted work. Dr. Mantero reports other from Astra-Zeneca, personal fees and other from MadicAir, other from Vivisol, outside the submitted work. Prof. Blasi reports grants and personal fees from astrazeneca, grants from bayer, grants and personal fees from chiesi, grants and personal fees from gsk, personal fees from guidotti, personal fees from grifols, grants and personal fees from insmed, personal fees from menarini, personal fees from mundipharma, personal fees from novartis, grants and personal fees from pfizer, personal fees from zambon, outside the submitted work.